From a search to an appointment
Four steps. The directories above are step one, and the questions for the call are in the section below.
Privacy: Your checkmarks stay in this browser on this device and are not sent to SteadySkin. Keep clinic names, plan details and your notes wherever you already keep them; do not enter them here.
- Owner
- You, from the three directories above
- Proof to keep
- Three to five practice names, each with a phone number
- Ready when
- You have names to work from, not a search to run
- Next action
- Check each name against your plan
- Owner
- You and your health plan
- Proof to keep
- Network status for each name, with the date you looked
- Ready when
- You know which of the names your plan pays for
- Next action
- Call the offices that are still on the list
- Owner
- You and the office staff
- Proof to keep
- Your own notes of what each office said
- Ready when
- Each name is a yes, a no, or a pointer somewhere else
- Next action
- Book the one you want to try, or work down the list
- Owner
- You
- Proof to keep
- One page: who you called, what they said, what is still open
- Ready when
- The next clinician can see what has already happened
- Next action
- Take that page to the first appointment
Which directories, and what does a listing prove?
Start with a verifiable professional directory, your health plan’s current network information if coverage matters, and referrals from clinicians you trust. The American Academy of Dermatology, the Global Vitiligo Foundation and each insurer publish public directories, linked above. Treat a listing as a starting point rather than a quality ranking. Evidence This statement has a dated source and is waiting for a clinician's sign-off. Pending clinical review
How to use this step
- Limited evidence
Dermatologists are physicians trained to diagnose and treat conditions of the skin, hair, and nails. The AAD directory can help identify candidates and explain board certification; office and insurer records can then confirm availability, referral requirements, and network status.
Check before moving on
- Depends on you
A credential or directory profile does not show how much current vitiligo care a clinician provides, how the office communicates, or whether its services match your needs. Directory and network information can also become outdated.
Questions for the clinic or clinician
Is this dermatologist board-certified, and where can I verify it?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Does this office currently evaluate and manage people with vitiligo?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Can the office confirm referral and network requirements before the visit?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What should I ask when I call the office?
Ask the office plainly about the clinician’s current experience with vitiligo and the services you may need. Useful fit questions concern diagnosis, treatment breadth, care for your age group, phototherapy access or referral pathways, and coordination when another specialist is needed. Evidence Evidence Evidence This statement has a dated source and is waiting for a clinician's sign-off. Pending clinical review
How to use this step
- Reasonably supported
I compared what the guidance asks of a vitiligo clinician. It covers classification, assessment of change, several treatment or no-active-treatment paths, associated health questions, and psychosocial impact. A clinician does not need to offer every service personally if the referral and coordination plan is clear.
Check before moving on
- Depends on you
Caseload alone does not prove quality, and a prestigious institution does not guarantee a good fit. I would compare current credentials, experience, services, availability, and communication rather than lean on a “top doctor” label.
Questions to ask when you call
What kinds of vitiligo care does the clinician provide regularly?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Can the office discuss medical, light-based, procedural, and no-treatment paths?
Saving keeps this on your device and needs JavaScript, which is off in this browser.If a service is not available here, where and how do you refer?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Does the clinician see people in my age group or with concerns like mine?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Can the visit include the emotional or daily-life impact?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
What should make me pause and ask more questions?
Pause when someone promises a cure or guaranteed result, treats a photograph as a complete diagnosis, or pressures you to buy a product. Pause too when they cannot explain material risks and alternatives. These signs do not prove misconduct, but they are good reasons to slow down, verify credentials and evidence, or seek another qualified opinion. Evidence Evidence Evidence This statement has a dated source and is waiting for a clinician's sign-off. Pending clinical review
How to use this step
- Reasonably supported
The current patient guidance I read says vitiligo has no single best treatment, and that treatment cannot guarantee a permanent cure. Proper diagnosis uses history and examination, and treatment choice depends on individual clinical and personal factors.
Check before moving on
- Depends on you
No checklist can grade a clinician from outside the relationship. Communication styles differ, and uncertainty expressed honestly is not a warning sign; certainty beyond what the evidence supports is the concern.
Questions for the clinic or clinician
What evidence supports this claim, and what are its limitations?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What alternatives, including waiting or no active treatment, are reasonable?
Saving keeps this on your device and needs JavaScript, which is off in this browser.Do you have a financial relationship with this product or service?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Lived experience - useful, real, and different for everyone
When a clinician dismisses the impact
Hearing “nothing can be done” or “it is only cosmetic” can make you doubt whether asking again is worth it. That dismissal is not proof that your goal is vain. Name the effect on your life and make one clear request.
- “This is affecting my daily life, and I want to discuss active options or a referral.”
- “Please note my request and the next step in my chart.”
- “If this is outside your focus, who would you trust for a second opinion?”
- “I may choose no treatment, but I want that to be an informed choice.”
A second opinion is not rude. A referral request is not demanding. You can also decide you do not want active treatment after you hear the choices.
Afterwards, write down what was offered, what was declined, and what the next step is. You can follow the plan, ask another clinician, pause, or choose no active treatment. Advocacy means getting enough information to choose - not being pushed to keep treating.
What if the clinician is not the right fit?
It is reasonable to seek another qualified opinion when the diagnosis, options, communication, or goals remain unclear. A transfer plan should preserve relevant records and an accurate list of current care. It should also carry explicit guidance from the care team about what happens while the new opinion is arranged. Evidence Evidence This statement has a dated source and is waiting for a clinician's sign-off. Pending clinical review
How to use this step
- Reasonably supported
When I read the patient surveys, the story that came up most was a long wait for the diagnosis, or being told there was nothing to be done. Vitiligo management can require follow-up because pattern, activity, goals, and response are reassessed rather than settled by a single snapshot. A concise record of the working diagnosis, prior options, outcomes, and open questions helps the next clinician understand what has already happened.
Check before moving on
- Depends on you
A new clinician may interpret the evidence differently or need to repeat part of the assessment. A second opinion offers another clinical judgment, not a guaranteed answer or result.
Questions for the clinic or clinician
Which records, images, and test results should I take to another clinician?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What should remain unchanged until care is transferred?
Saving keeps this on your device and needs JavaScript, which is off in this browser.What question do I most need the second opinion to answer?
Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Journal of the European Academy of Dermatology and VenereologyGuideline · Regulatory / guideline, tier 1Relevant relationship disclosed
- Published
- SteadySkin last checked
What this source can and cannot tell you
Why the independence label says this: The journal is the publisher. This label refers to extensive author relationships disclosed for the recommendation, not to the journal itself.
What this source supports
It supports current expert-consensus terminology, clinical assessment, disease-activity evaluation, treatment-goal discussion, and shared decision-making. Its modified assessment check list names where the patches are as a disease feature, and gives genital involvement as its own example. It records white hairs as an item of its own, apart from what the vitiligo has done in the past six months. Its classification table keeps mucosal vitiligo as a subtype, both across more than one site and at one site alone. It supports planning care around what is there to work with, and its example is hair that still has its color. It names stable vitiligo and active vitiligo as two different states that change the care plan. Its shared-decision steps ask what the patient wants from care. At the time it was written, one cream form of a newer drug type had just been approved. Pill forms of that same drug type were still being studied.
What it does not support
It is not independent comparative proof. It cannot diagnose a reader from a description or photograph. It gives no figure for genital involvement, and it does not name lichen sclerosus. It does not set out the Vitiligo European Task Force grading scale. It puts no figure on white hairs and predicts nothing for one person.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- British Journal of Dermatology (Eleftheriadou V, et al.)Guideline · Regulatory / guideline, tier 1Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports the clinical history and assessment domains, evaluation of associated autoimmune conditions, its recommendation for thyroid function and antithyroid antibody screening, current classification context, treatment-option map, psychosocial assessment, medical photography and the limits of pediatric evidence. Its classification table defines mucosal vitiligo as the oral or genital mucosae. One mucosal site alone is filed as undetermined or unclassified. Its differential diagnosis table lists genital or extragenital lichen sclerosus among the conditions that can be mistaken for vitiligo. That table also lists eczema, psoriasis, lichen planus, pityriasis alba and piebaldism. It calls autoimmunity a contributor to the pathogenesis of vitiligo. It reports an earlier review finding a possible negative impact on intimacy and sexual functioning. It tells clinicians to discuss the psychosocial impact of living with the condition. R28 offers a skin camouflage visit to people who want one. R10 to R14 name potent or very potent topical steroids as the first choice, with a topical calcineurin-inhibitor cream as an option for the face. These are different creams with different proof behind them. R20 names narrowband UVB as the first light option. It says the skin often does better on the face and trunk than on hands and feet. It says there is not enough proof to use any one current pill alone for vitiligo that is not changing. R25 and Table 2 keep cell grafting for vitiligo that is not changing and did not respond to other care. They also say a doctor cannot always tell if the vitiligo has truly stopped changing.
What it does not support
It was designed for UK care and reviewed literature through May 2019; it does not establish a universal testing plan, prescribe an individual plan, or establish current US labeling or coverage. Its differential diagnosis table is a list, not a method a reader can apply to their own skin. It does not say how to tell any two of those conditions apart. It gives no figure for how often vitiligo affects genital skin.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · Patient education, tier 5Independent source
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports a patient-facing description of clinician diagnosis using history and examination, possible use of a Wood lamp and selected tests, broad treatment categories, variable response and whole-person support.
What it does not support
It is educational context, not primary efficacy evidence, an online diagnostic method or a universal testing checklist.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.
- American Academy of DermatologyPatient education · Patient education, tier 5Independence not established
- Published
- SteadySkin last checked
What this source can and cannot tell you
What this source supports
Supports current US patient-language context that lighter patches have multiple causes, dermatologists diagnose vitiligo from history and examination, treatment is optional and several broad management paths exist.
What it does not support
The page acknowledges support from Incyte Dermatology, so it does not independently establish drug efficacy or comparative superiority.
Claim-specific review for this source is still in progress. Only the source-level evidence and limits are shown here.